SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
ChargePoint held its 2026 Annual Meeting of Stockholders on July 21, 2026, with shareholders voting on three proposals: election of Class III directors (Bruce Chizen, Michael Linse, and Richard Wilmer), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. Final vote tallies certified by the Inspector of Election are disclosed.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of WM Technology's 2026 Annual Meeting of Stockholders held on July 16, 2026. The filing presents voting outcomes for four proposals: (1) declassification of the board (failed), (2) advisory say-on-pay vote (passed), (3) auditor ratification (passed), and (4) election of three Class II directors (passed). The detailed vote tallies and quorum information (84% attendance) are material to shareholders assessing governance and board composition.
View raw filing on EDGAR →Shareholders voted at a reconvened meeting on July 20, 2026, approving two proposals: warrant exercisability (93.3% in favor) and an increase in authorized share capital by 10 million shares (89.8% in favor). Both proposals passed by majority vote, materially affecting the company's capital structure and warrant obligations.
View raw filing on EDGAR →This Item 5.07 discloses the results of Rein Therapeutics' 2026 Annual Meeting of Stockholders held on July 20, 2026, including voting outcomes on director elections (Josef H. von Rickenbach and Reinhard J. Ambros, Ph.D.), approval of an amendment to increase authorized common shares from 100 million to 200 million, ratification of CBIZ CPAs P.C. as independent auditor, and advisory approval of named executive officer compensation. The filing presents detailed vote tallies for each matter, which is the core disclosure required under Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →Aware Inc held its Annual Meeting of Shareholders on July 15, 2026, with final voting results reported on four matters: election of Class III directors (Amlani and Faubert), advisory approval of named executive officer compensation, ratification of RSM US LLP as independent auditor, and approval of a 1,000,000-share increase to the 2023 Equity and Incentive Plan.
View raw filing on EDGAR →The filing discloses results of a shareholder vote at an annual meeting held on July 21, 2026, where shareholders approved all proposals including an amendment to extend the SPAC's deadline to complete an initial business combination. This is a direct disclosure of shareholder vote results under Item 5.07, and the extension approval is material to investors as it affects the timeline and viability of the proposed business combination with a critical mineral target company announced on July 17, 2026.
View raw filing on EDGAR →Stockholders voted on July 21, 2026 to approve an assignment for the benefit of creditors followed by voluntary dissolution and liquidation, with 13,348,600 votes in favor, 100,879 against, and 44,093 abstentions (69% quorum of outstanding voting power).
View raw filing on EDGAR →The 6-K discloses the results of Ohmyhome Limited's Annual General Meeting held on July 21, 2026, where shareholders voted on eleven proposals. The filing presents voting tallies (For/Against/Abstain) for each proposal, including material capital structure changes (authorized share capital increase, capital reduction, share subdivision, share consolidation), director re-appointments, and auditor ratification. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and the capital restructuring proposals are material to investors' assessment of the company's share structure and dilution risk.
View raw filing on EDGAR →The 6-K discloses a "Consolidated Synthetic Voting Map" for an Extraordinary General Meeting scheduled for July 22, 2026, presenting consolidated remote voting instructions received by shareholders on items 2 and 3 (election of Board of Directors and Chairman). While technically pre-vote disclosure rather than final results, this represents material shareholder voting information on board composition and leadership—a governance matter affecting reasonable investor assessment of the company's direction and control.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Picard Medical's Annual Meeting of Stockholders held on July 17, 2026. The filing presents voting results for six matters: election of four directors, advisory approval of named executive officer compensation, frequency of future advisory votes on compensation, approval of a reverse stock split amendment (1-for-15 to 1-for-50 ratio), designation of Class B common stock with 20 votes per share, and ratification of MaloneBailey LLP as independent auditor. All matters were approved. The reverse stock split authorization and Class B voting structure are material governance and capital structure changes affecting shareholder rights and equity value.
View raw filing on EDGAR →Radnostix Inc. held its Annual Meeting on July 16, 2026, with shareholders voting on three proposals: election of five directors, ratification of independent auditor Haynie & Company, and approval of the 2026 Incentive Plan. Detailed vote tallies were disclosed for each proposal.
View raw filing on EDGAR →VolitionRx held its annual meeting of stockholders on July 17, 2026, with voting results on five proposals: election of seven directors, ratification of auditor (Sadler, Gibb & Associates, LLC), advisory vote on named executive officer compensation, amendment to reduce authorized shares from 325 million to 150 million, and approval of the 2026 Stock Incentive Plan.
View raw filing on EDGAR →The 6-K discloses the results of an extraordinary general meeting held on July 21, 2026, where shareholders voted on a 1-for-10 share consolidation resolution. The resolution passed with 99.34% of votes cast in favor. Share consolidations are material capital structure changes that affect all shareholders' holdings and voting power, and the filing explicitly reports the voting results by share class and vote count, matching the `shareholder_vote_results` taxonomy.
View raw filing on EDGAR →The filing discloses results of My Size, Inc.'s 2026 annual stockholder meeting held on July 21, 2026, under Item 5.07. The company reports voting outcomes for five proposals: election of two Class II directors (both passed), an advisory say-on-pay vote (passed), authorization for reverse stock splits up to 1-for-30 (passed), approval of blank check preferred stock authorization (failed to achieve majority of outstanding shares), and ratification of Somekh Chaikin as independent auditor (passed). The failure of the blank check preferred stock proposal is material to investors assessing the company's capital structure flexibility.
View raw filing on EDGAR →The 6-K discloses the results of Formula Systems' 2026 annual general meeting of shareholders held on July 20, 2026. The filing reports voting outcomes on eight proposals, including re-election of five board members (Marek Panek, Rafal Kozlowski, Itay Meroz, Karolina Rzonca-Bajorek, and Gabriela Żukowicz) and re-appointment of the independent auditor (Ziv Haft/BDO Israel), all of which were approved. This is a classic shareholder_vote_results disclosure under the 8-K taxonomy Item 5.07 equivalent.
View raw filing on EDGAR →ZeroStack Corp. held an annual shareholder meeting at which eight proposals were submitted to a vote, including director elections, auditor reappointment, equity issuance approval, equity plan amendments, executive compensation approval, incorporation jurisdiction change, bylaw amendment establishing a classified board with staggered director terms, and meeting adjournment authority. All eight proposals were approved by shareholders.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of Transcode Therapeutics' 2026 Annual Meeting of Stockholders held on July 20, 2026. The filing details voting outcomes on seven proposals, including approval of convertible preferred stock issuances (Proposals 1–2), a Standby Equity Purchase Agreement and convertible notes (Proposal 3), election of six directors (Proposal 4), amendment to the 2021 Stock Option and Incentive Plan (Proposal 5), ratification of the independent auditor (Proposal 6), and adjournment authority (Proposal 7). All proposals were approved. The disclosure is material because shareholder approval of dilutive equity issuances and director elections directly affects investor interests and capital structure.
View raw filing on EDGAR →Stockholders approved by written consent on July 19, 2026, the issuance of PIPE shares, convertible notes, warrants, and sponsor incentive shares under Nasdaq Rule 5635(b), and the adoption of a new equity plan under Nasdaq Rule 5635(c).
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Healthcare Triangle's July 17, 2026 annual shareholder meeting. The filing presents voting tallies for nine proposals, including director elections, auditor ratification, stock plan amendments, and critically, approval of multiple dilutive issuances (2.8M shares to SecureKloud, up to 11.9M shares in the Teyame transaction, convertible debentures, and ELOC securities). These shareholder approvals of substantial equity issuances are material to investors assessing dilution and capital structure.
View raw filing on EDGAR →This 6-K discloses the results of shareholder votes held on July 20, 2026, including three separate meetings (Class A, Class B, and Extraordinary General Meeting). The disclosure reports voting results on material matters including: (1) increase of voting rights for Class B shares from 30 to 800 votes; (2) repurchase of 3.77 million Class A shares held by the CEO's entity; (3) issuance of 3.77 million Class B shares to the CEO's entity; (4) increase in authorized share capital; (5) adoption of amended articles of association; and (6) approval of a VIE acquisition of Beijing Tongsheng Technology with issuance of 64.2 million Class A shares as consideration. These are material governance and capital structure changes requiring shareholder approval.
View raw filing on EDGAR →This is a major holdings notification (TR-1 form) disclosing that The Capital Group Companies, Inc. and Capital Research and Management Company crossed above the 17.00% voting threshold in Ryanair Holdings PLC on 16 July 2026, increasing from 16.08% to 17.03%. This is a material change in share ownership structure that would affect investor assessment of control and influence.
View raw filing on EDGAR →This Item 5.07 discloses the results of a special stockholder meeting held on July 16, 2026, where shareholders voted on three proposals, including approval of a merger agreement with KL Criss Cross Intermediate, LLC. Proposal 1 (the Merger Agreement Proposal) was approved with 23,356,105 votes in favor versus 12,309 against, and Proposal 2 (Advisory Merger-Related Compensation) was also approved. This is a classic shareholder vote results disclosure that is material because it confirms stockholder approval of a transformative merger that will result in the company being delisted from NASDAQ and deregistered under the Securities Exchange Act.
View raw filing on EDGAR →The filing discloses results of the 2026 Annual Meeting of Stockholders held on July 14, 2026, including voting outcomes on three proposals: election of five board directors (Proposal 1), ratification of Weinberg & Company as independent auditor (Proposal 2), and adjournment authority (Proposal 3). This is a classic Item 5.07 shareholder vote results disclosure with detailed vote tallies for each nominee and proposal.
View raw filing on EDGAR →Stockholders approved four substantive proposals at a Special Meeting: approval of warrant issuances from a registered direct offering and private placement, authorization to increase authorized common shares from 260 million to 600 million, and authorization for a reverse stock split at a 1-for-10 to 1-for-50 ratio. The certified voting results, including vote counts for, against, abstentions, and broker non-votes for each matter, are disclosed.
View raw filing on EDGAR →Entera Bio held its 2026 Annual Meeting of Shareholders on July 14, 2026, with voting results disclosed covering ten proposals including director elections (Sean Ellis, Steven D. Rubin, Geno H. Germano), executive and director compensation approvals, equity plan amendments, and auditor ratification.
View raw filing on EDGAR →IRIDEX Corporation held its 2026 Annual Meeting of Stockholders on July 10, 2026, with voting results confirming the election of five directors (Nick Chen, Beverly A. Huss, Patrick Mercer, William Moore, and Scott Shuda), ratification of BPM LLP as independent auditor, and advisory approval of named executive officer compensation.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from BioAtla's Annual Meeting held July 16, 2026. The filing presents final voting tallies for three proposals: election of two Class III directors (Jay M. Short and Edward Williams), ratification of Ernst & Young LLP as independent auditor, and a non-binding advisory vote on named executive officer compensation. All three proposals passed with majority support, making this a routine but material governance disclosure that affects investor understanding of board composition and auditor appointment.
View raw filing on EDGAR →Blue Gold Ltd is soliciting shareholder votes on two material proposals at an Extraordinary General Meeting scheduled for July 24, 2026: (1) authorization for a reverse stock split at a ratio between 1:2 and 1:200 to address Nasdaq minimum bid price compliance, and (2) amendment and restatement of the Memorandum and Articles of Association to reflect the reverse split. The reverse stock split is material to investors as it directly addresses the company's trading price and listing status in response to delisting risk.
View raw filing on EDGAR →The 6-K discloses the results of an Extraordinary General Meeting held on July 13, 2026, where shareholders voted on three proposals: (1) revision of terms for allotment of up to 5,000,000 Class B shares to Xingji Zhangpingting Limited with board-determined consideration; (2) approval of an offering of up to 10,000,000 Class A shares and filing of a Form F-1 registration statement with the SEC; and (3) authorization to adjourn the meeting if necessary. All three proposals passed with overwhelming majorities (99.99% for Proposals 1 and 2, 100% for Proposal 3). The approval of a material equity offering and share allotment makes this material to investors.
View raw filing on EDGAR →Item 5.07 discloses the results of Versus Systems' annual shareholder meeting held July 16, 2026, with voting results for the election of four directors (Juan Carlos Barrera, David Catzel, Aric Spitulnik, and Luis Goldner) and a proposal to adjourn the meeting. All proposals were approved with clear majorities. This is a standard shareholder vote results disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →The 6-K discloses the results of an Extraordinary General Meeting held on July 10, 2026, where shareholders voted on seven proposals. The filing presents detailed vote tallies for each proposal, including the creation of Class A shares with 100 votes per share, a massive increase in authorized share capital (from 200 million to 100 trillion shares), and approval of amended memorandum and articles of association. These governance and capital structure changes are material to investors and directly correspond to Item 5.07 (shareholder vote results).
View raw filing on EDGAR →This Item 5.07 disclosure reports the final results of Treasure Global Inc's 2026 Annual Stockholders Meeting held on July 14, 2026, including the election of seven directors and ratification of WWC, P.C. as the independent auditor. The detailed vote tallies for each director nominee and the auditor ratification proposal are the core content, making this a textbook shareholder vote results disclosure.
View raw filing on EDGAR →Plum IV shareholders voted on July 10, 2026 to approve an Extension Amendment extending the business combination deadline from July 16, 2026 to January 16, 2027, with optional monthly extensions up to July 16, 2027. The proposal passed with 17,581,000 votes in favor, 2,132,072 against, and 52 abstentions, representing 81.32% of voting power.
View raw filing on EDGAR →This is a call notice and manual for an Extraordinary General Meeting scheduled for August 18, 2026, inviting shareholders to vote on fixing the board size at 13 members, electing two new directors (Daniel Barriuso Rojo and Gilson Finkelsztain), and confirming the board composition. However, the meeting has not yet occurred as of the filing date (July 16, 2026), so this is a prospective notice rather than a disclosure of actual vote results. The taxonomy's `shareholder_vote_results` type is defined as "Results of a vote at an annual or special meeting," which typically applies post-meeting. This document is pre-meeting guidance, making it more aligned with governance-related shareholder communication, but the closest available category is `shareholder_vote_results` given the focus on board elections and shareholder voting procedures.
View raw filing on EDGAR →Rent the Runway held its Annual Meeting of Stockholders on July 14, 2026, with shareholders voting on 12 items including election of two Class II directors (Teri Bariquit and Daniel Rosensweig), ratification of PricewaterhouseCoopers LLP as auditor, approval of amendments to the Certificate of Incorporation, and approval of an increase to the 2021 Incentive Plan. All items passed with detailed vote tallies reported.
View raw filing on EDGAR →Cosmos Health held its 2026 Annual Meeting of Stockholders on July 15, 2026, where shareholders voted on four proposals: election of six directors, ratification of the independent auditor, approval of the 2026 Equity Omnibus Plan, and approval of Series B Preferred Stock designation and issuance. All four proposals passed with affirmative vote percentages ranging from 78.98% to 84.24%.
View raw filing on EDGAR →This 8-K Item 5.07 discloses the results of a Special Meeting of Stockholders held on July 15, 2026, with voting results on seven proposals. The filing reports final vote tallies from the Inspector of Elections for each proposal, including approval of warrant issuances exceeding 19.99% of outstanding shares (Proposals 1-5), authorization for a reverse stock split (Proposal 6), and meeting adjournment authority (Proposal 7). All proposals were approved. The warrant issuances and reverse split authorization are material capital structure events requiring shareholder approval under NYSE American rules.
View raw filing on EDGAR →This Item 5.07 disclosure reports the final voting results from Advanced Drainage Systems' 2026 Annual Meeting of Stockholders held on July 16, 2026. The filing presents detailed tabulations for three proposals: election of nine directors, ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of executive compensation. All three proposals passed with substantial majorities. This is a classic shareholder vote results disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from DOMO's Annual Meeting held July 14, 2026. The filing reports voting outcomes on three proposals: election of eight directors (all elected), ratification of Ernst & Young LLP as independent auditor (ratified), and advisory approval of named executive officer compensation (approved). The high quorum (95.86% of voting power) and detailed vote tallies are characteristic of shareholder_vote_results disclosures.
View raw filing on EDGAR →At a Special Meeting of Shareholders held on July 14, 2026, shareholders approved the issuance of 2,401,615 shares upon conversion of Series D and E preferred stock and an amendment to increase authorized common shares from 15 million to 100 million. These votes reflect material changes to the company's capital structure and dilution profile.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of an extraordinary general meeting of shareholders held on July 15, 2026, where PCSC shareholders voted on and approved multiple proposals including the Business Combination Proposal, Domestication Proposal, Governing Documents Proposal, Nasdaq Proposal, and equity plan proposals. The filing provides detailed voting tallies for each proposal, quorum information (75.65% of voting power present), and confirms approval of all substantive matters. This is a classic shareholder vote results disclosure material to investors evaluating the company's business combination transaction.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on July 14, 2026. The filing reports final voting tallies for three proposals: election of three Class II directors (Patricia Gauthier, Jonathan Lieber, and Frederick E. Pierce), non-binding advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. This is the quintessential shareholder_vote_results event type under Item 5.07.
View raw filing on EDGAR →The 6-K discloses results of an annual general meeting of shareholders held on July 13, 2026, where shareholders voted on three proposals: (1) a share consolidation proposal (approved 256,359,455 for), (2) an M&A notice amendment proposal (approved 256,418,884 for), and (3) an adjournment proposal (approved 256,592,808 for). This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, with detailed voting tallies and outcomes. The share consolidation authorization (up to 1-for-400) and bylaw amendments are material governance matters affecting capital structure and shareholder rights.
View raw filing on EDGAR →This exhibit discloses the results of Sigma Lithium's 2026 Annual Meeting of Shareholders held on June 30, 2026, including the election of all five director nominees (Ana Cristina Cabral re-elected with 97.41%, Marcelo Paiva with 83.97%, Junaid Jafar with 99.94%, Alexandre Rodrigues Cabral with 99.94%, and Kátia Abreu with 99.97%) and approval of the auditor appointment (Grant Thornton LLP with 99.95% support). The disclosure includes detailed voting tallies and percentages, which is the hallmark of shareholder vote results disclosure. This is material as it confirms board composition and auditor appointment for the ensuing year.
View raw filing on EDGAR →This exhibit discloses the voting results from Sigma Lithium's Annual and Special Meeting of Shareholders held June 30, 2026, including shareholder approval of fixing the board at five directors, election of five named directors (Ana Cristina Cabral, Marcelo Paiva, Junaid Jafar, Alexandre Rodrigues Cabral, and Kátia Abreu), and appointment of Grant Thornton Auditores Independentes Ltda. as auditors. The disclosure explicitly states it is furnished "in accordance with Section 11.3 of National Instrument 51-102," confirming this is a formal shareholder vote results disclosure material to investors' understanding of corporate governance.
View raw filing on EDGAR →At a Special Meeting of Stockholders held on July 10, 2026, shareholders voted on a reverse stock split (1:5 ratio) and an adjournment proposal; both proposals failed to receive majority approval, with the reverse stock split receiving 4,851,288 votes for versus 9,373,945 against.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of the Annual Meeting of Stockholders held on July 9, 2026, where stockholders voted on two matters: (1) election of six directors to the Board, with detailed voting tallies for each nominee showing all were elected, and (2) ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026, which was approved. The disclosure includes complete voting results with votes cast "for," "against," and abstentions for each proposal, which is the core content of a shareholder vote results disclosure under Item 5.07.
View raw filing on EDGAR →The 6-K furnishes the voting results of GeoPark's Annual General Meeting held on July 14, 2026, disclosing the approval of director re-elections (James F. Park, Robert A. Bedingfield, Carlos E. Macellari, Brian F. Maxted, Constantin Papadimitriou, Felipe Bayon), new director elections (Gabriel Gilinski, Dorita Gilinski, Camilo Martinez), and auditor appointment (Ernst & Young Audit S.A.S.) with specific vote tallies for each proposal. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and is material as it confirms the composition of the board and auditor for the fiscal year.
View raw filing on EDGAR →The 6-K discloses the results of an extraordinary general meeting of shareholders held on July 14, 2026, with detailed voting tallies for five proposals. All proposals passed, including a significant increase in authorized share capital (from US$50,000 to US$2,500,000), approval of share consolidations at ratios between 1-for-10 and 1-for-250, and amendments to the memorandum and articles of association. These capital structure changes are material to investors' assessment of the company's equity and voting rights.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of the Company's annual stockholder meeting held on July 8, 2026, including election of two Class I Directors (Bradley V. Stoots and Steven G. Hooser), ratification of HoganTaylor LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents voting tallies for each matter, which is the core content of shareholder vote results disclosures.
View raw filing on EDGAR →